PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
RETL vs. CURE
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility

Key characteristics


RETLCURE
YTD Return8.48%20.33%
1Y Return89.80%53.17%
3Y Return (Ann)-42.65%1.00%
5Y Return (Ann)0.11%16.55%
10Y Return (Ann)2.65%15.42%
Sharpe Ratio1.221.39
Sortino Ratio1.911.87
Omega Ratio1.221.24
Calmar Ratio0.880.98
Martin Ratio4.885.55
Ulcer Index16.29%7.88%
Daily Std Dev65.17%31.55%
Max Drawdown-91.51%-69.19%
Current Drawdown-81.92%-14.85%

Correlation

-0.50.00.51.00.5

The correlation between RETL and CURE is 0.48, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.

Performance

RETL vs. CURE - Performance Comparison

In the year-to-date period, RETL achieves a 8.48% return, which is significantly lower than CURE's 20.33% return. Over the past 10 years, RETL has underperformed CURE with an annualized return of 2.65%, while CURE has yielded a comparatively higher 15.42% annualized return. The chart below displays the growth of a $10,000 investment in both assets, with all prices adjusted for splits and dividends.


500.00%1,000.00%1,500.00%2,000.00%2,500.00%3,000.00%JuneJulyAugustSeptemberOctoberNovember
550.47%
2,571.59%
RETL
CURE

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


RETL vs. CURE - Expense Ratio Comparison

RETL has a 0.99% expense ratio, which is lower than CURE's 1.08% expense ratio.


CURE
Direxion Daily Healthcare Bull 3x Shares
Expense ratio chart for CURE: current value at 1.08% compared with the broader market ranging from 0.00% to 2.12%.0.50%1.00%1.50%2.00%1.08%
Expense ratio chart for RETL: current value at 0.99% compared with the broader market ranging from 0.00% to 2.12%.0.50%1.00%1.50%2.00%0.99%

Risk-Adjusted Performance

RETL vs. CURE - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Direxion Daily Retail Bull 3X Shares (RETL) and Direxion Daily Healthcare Bull 3x Shares (CURE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


RETL
Sharpe ratio
The chart of Sharpe ratio for RETL, currently valued at 1.22, compared to the broader market-2.000.002.004.006.001.22
Sortino ratio
The chart of Sortino ratio for RETL, currently valued at 1.91, compared to the broader market-2.000.002.004.006.008.0010.0012.001.91
Omega ratio
The chart of Omega ratio for RETL, currently valued at 1.22, compared to the broader market1.001.502.002.503.001.22
Calmar ratio
The chart of Calmar ratio for RETL, currently valued at 0.88, compared to the broader market0.005.0010.0015.000.88
Martin ratio
The chart of Martin ratio for RETL, currently valued at 4.88, compared to the broader market0.0020.0040.0060.0080.00100.004.88
CURE
Sharpe ratio
The chart of Sharpe ratio for CURE, currently valued at 1.39, compared to the broader market-2.000.002.004.006.001.39
Sortino ratio
The chart of Sortino ratio for CURE, currently valued at 1.87, compared to the broader market-2.000.002.004.006.008.0010.0012.001.87
Omega ratio
The chart of Omega ratio for CURE, currently valued at 1.24, compared to the broader market1.001.502.002.503.001.24
Calmar ratio
The chart of Calmar ratio for CURE, currently valued at 0.98, compared to the broader market0.005.0010.0015.000.98
Martin ratio
The chart of Martin ratio for CURE, currently valued at 5.55, compared to the broader market0.0020.0040.0060.0080.00100.005.55

RETL vs. CURE - Sharpe Ratio Comparison

The current RETL Sharpe Ratio is 1.22, which is comparable to the CURE Sharpe Ratio of 1.39. The chart below compares the historical Sharpe Ratios of RETL and CURE, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio0.000.501.001.50JuneJulyAugustSeptemberOctoberNovember
1.22
1.39
RETL
CURE

Dividends

RETL vs. CURE - Dividend Comparison

RETL's dividend yield for the trailing twelve months is around 1.22%, less than CURE's 1.26% yield.


TTM20232022202120202019201820172016201520142013
RETL
Direxion Daily Retail Bull 3X Shares
1.22%1.35%0.71%0.22%0.19%0.92%1.19%0.01%2.60%0.00%0.00%0.00%
CURE
Direxion Daily Healthcare Bull 3x Shares
1.26%2.02%0.38%0.02%0.17%0.40%0.70%0.18%0.00%0.00%0.00%1.24%

Drawdowns

RETL vs. CURE - Drawdown Comparison

The maximum RETL drawdown since its inception was -91.51%, which is greater than CURE's maximum drawdown of -69.19%. Use the drawdown chart below to compare losses from any high point for RETL and CURE. For additional features, visit the drawdowns tool.


-80.00%-60.00%-40.00%-20.00%0.00%JuneJulyAugustSeptemberOctoberNovember
-81.92%
-14.85%
RETL
CURE

Volatility

RETL vs. CURE - Volatility Comparison

Direxion Daily Retail Bull 3X Shares (RETL) has a higher volatility of 14.05% compared to Direxion Daily Healthcare Bull 3x Shares (CURE) at 8.65%. This indicates that RETL's price experiences larger fluctuations and is considered to be riskier than CURE based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


5.00%10.00%15.00%20.00%25.00%JuneJulyAugustSeptemberOctoberNovember
14.05%
8.65%
RETL
CURE